Prevalence of Metabolic Syndrome in individuals with Type 2 Diabetes Mellitus

Neto, José Cláudio Garcia Lira; Xavier, Mayra de Almeida; Borges, José Wicto Pereira; Araújo, Márcio Flávio Moura de; Damasceno, Marta María Coelho; Freitas, Roberto Wagner Júnior Freire de

doi:10.1590/0034-7167-2016-0145

Cited by 23 publications

(13 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence worldwide ranges from 45.8% and 96.3%. [11][12] Similar study done at diabetes centre in Galle, Sri Lanka showed the prevalence of metabolic syndrome in Type 2 DM population to be 70% which was consistent with our study. 13 Our study showed 84 male and 58 female participants had metabolic syndrome which was not similar to the study by Ford et al 4 and Nsiah K et al 14 which showed higher prevalence of metabolic syndrome in females.…”

Section: Discussionsupporting

confidence: 91%

“…17 Additionally, in our study 70 (35%), 41 (20.5%) and 29 (14.5%) of the patients had three, four or five altered components of metabolic syndrome respectively, which were higher than those found among diabetics in other study. 17 Age groups 45-54, 55-64 and 65-74 years who had more than three components of metabolic syndrome were 14 (20%), 20 (28.6%) and 19 (27.1%) respectively, which indicates that the participants of the age group 45-54 years are likely to have a high prevalence of metabolic syndrome, irrespective of sex. Hence, prevention and control measures should be taken when the age approaches since the prevalence of metabolic syndrome increases with age.…”

Section: Discussioncontrasting

confidence: 56%

See 1 more Smart Citation

Prevalence of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus in a Tertiary Care Hospital

Shakya

2019

Med. J. Shree Birendra Hosp.

View full text Add to dashboard Cite

Introduction: Diabetes mellitus is associated with various metabolic disorders, which leads to the progression of the disease and its complications. The aim of the study is to find out prevalence of metabolic syndrome and its association with the components and demographic variables. Methods: This cross-sectional study was conducted among diabetes mellitus patients at a Tertiary level teaching hospital over a period of one year (April 2015 to March 2016). The study involved the use of a questionnaire to obtain information on diabetes by performing anthropometric measurements and corroborating it with respective blood samples collected for the measurement of biochemical parameters, fasting blood glucose and lipid profile. Metabolic syndrome was defined according to the current guidelines, revised in 2005 by the National Heart, Lung and Blood Institute and the American Heart Association. Statistical Package for the Social Sciences Version 20 was used as a tool for statistical analysis. Results: This cross-sectional study involved 200 type 2 diabetes mellitus patients. The prevalence of metabolic syndrome was 71% in the studied Nepalese population. Central obesity (77.5%) and hypertension (76.8%) were the commonest risk factors. It was followed by dyslipidemia among which 65.5% had high triglyceride level and 50.7% had low level of high density lipoprotein cholesterol. Higher prevalence of metabolic syndrome was seen in male patients with type 2 diabetes which accounted for 84 (73.3%). Three components of metabolic syndrome were seen among 70 (35%) and five components among 29 (14.5%) patients. Among the patients who were studied, the age group 45 to 54, 55 to 64 and 65 to 74 years had 14 (20%), 20 (28.6%) and 19 (27.1%) of more than three components of metabolic syndrome respectively. Conclusions: The prevalence of metabolic syndrome was 71% among the patients with type 2 diabetes, where high prevalence was seen among males. In our study central obesity and hypertension along with increasing age were the most common component causing metabolic syndrome.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussioncontrasting

confidence: 56%

Prevalence of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus in a Tertiary Care Hospital

Shakya

2019

Med. J. Shree Birendra Hosp.

View full text Add to dashboard Cite

show abstract

“…Hence, a multidisciplinary approach in health is necessary 22 in order to reduce factors responsible for the emergence of the syndrome and its respective outcomes. Nurses routinely deal with the imbalance of these factors and have an important role on the diagnosis, healthcare planning, strategy interventions, and control of this syndrome 21 .…”

Section: Discussionmentioning

confidence: 99%

Síndrome metabólica: análise conceitual no contexto da enfermagem

Félix

Nóbrega

2019

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

Objetivo analisar o conceito síndrome metabólica e identificar respectivos atributos essenciais, antecedentes e consequentes no contexto da enfermagem. Método análise conceitual, a partir dos passos metodológicos de um modelo. Realizou-se revisão integrativa, por meio de acesso on-line a quatro bases de dados: Medical Literature Analysis and Retrieval System Online, Scientific Electronic Library Online, Literatura Latino-Americana em Ciências da Saúde e Índice Bibliográfico Español en Ciencias de la Salud. Resultados os atributos essenciais mais frequentes envolveram os critérios diagnósticos da síndrome metabólica. Alimentação inadequada e sedentarismo destacaram-se como antecedentes mais comuns da síndrome, e os consequentes foram ocorrências de doenças cardiovasculares e diabetes mellitus tipo 2. Como implicação, tem-se o destaque de relevantes dados empíricos para definição ampla do conceito. Conclusão foi possível analisar o conceito em estudo no que concerne aos atributos essenciais, antecedentes e consequentes, definindo-o operacionalmente como potencial fenômeno de enfermagem que demanda cuidados direcionados para redução do risco e da morbimortalidade por doenças cardiovasculares.

show abstract

“…6 Those with metabolic syndrome have up to 24.5-fold increased risk of developing T2DM with overt hyperglycemia, 7 and 50-72% of those with T2DM have metabolic syndrome. 8,9 Both metabolic syndrome and diabetes mellitus (DM) are on the rise as a pandemic global health concern. DM currently affects 425 million people worldwide, with an estimated increase to 629 million by 2045.…”

Section: Introductionmentioning

confidence: 99%

<p>Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?</p>

Aldibbiat

Al-Sharefi

2020

COPD

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) and diabetes mellitus (DM) are chronic health conditions with significant impacts on quality and extent of life. People with COPD and DM appear to have worse outcomes in each of the comorbid conditions. Treatment with corticosteroids in acute exacerbation of COPD (AECOPD) has been shown to reduce treatment failure and exacerbation relapse, and to shorten length of hospital stay, but not to affect the inexorable gradual worsening of lung function. Treatment with corticosteroids can lead to a wide spectrum of side effects and complications, including worsening hyperglycemia and deterioration of diabetes control in those with pre-existing DM. The relationship between COPD and DM is rather complex and accumulating evidence indicates a distinct phenotype of the comorbid state. Several randomized controlled trials on corticosteroid treatment in AECOPD excluded people with DM or did not report on outcomes in this subgroup. As such, the perceived benefits of corticosteroids in AECOPD in people with DM have not been validated. In people with COPD and DM, the detrimental side effects of corticosteroids are guaranteed, while the benefits are not confirmed and only presumed based on extrapolation from the general COPD population. Therefore, the potential for harm when prescribing corticosteroids for AECOPD in people with DM cannot be excluded.

show abstract

Prevalence of Metabolic Syndrome in individuals with Type 2 Diabetes Mellitus

Abstract: it is essential to take preventive actions and develop studies that help to identify the factors associated with this syndrome.

Cited by 23 publications

References 8 publications

Prevalence of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus in a Tertiary Care Hospital

Prevalence of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus in a Tertiary Care Hospital

Síndrome metabólica: análise conceitual no contexto da enfermagem

<p>Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?</p>

Contact Info

Product

Resources

About